Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

February 26, 2021February 26, 2021

3D Imaging System May Have Applications in ALS Research

News

A novel system for three-dimensional (3D) imaging of zebrafish may be useful for studying the motor and neuronal deficits linked with amyotrophic lateral sclerosis (ALS), a study suggests. The system ... Read more

February 9, 2021February 9, 2021

Stretchable Electronics May Allow Wearable Sensors to Diagnose ALS

News

Stretchable electronics that are “intrinsically” stretchable — meaning they have tissue-like mechanical properties that integrate sensory devices with human skin — can better detect signals from a patient’s body than current, ... Read more

February 3, 2021February 3, 2021

Imaging Technique Measures Mitochondrial Abnormalities in ALS

News

An imaging technique, called 31-phosphorus magnetic resonance spectroscopy (MRS), can be used to assess mitochondrial abnormalities in people with amyotrophic lateral sclerosis (ALS), a new study demonstrates. This non-invasive procedure ... Read more

February 1, 2021February 1, 2021

TDP-43 Protein Abnormalities in ALS Linked to DNA Damage

News

Abnormalities in the activity of the protein TDP-43, whose gene is often mutated in amyotrophic lateral sclerosis (ALS), can increase DNA damage in cells, a study shows. These findings shed ... Read more

January 29, 2021January 29, 2021

Melatonin Might Benefit ALS Patients, But More Research Needed

News

People with amyotrophic lateral sclerosis (ALS) who use melatonin have better survival outcomes and experience slower disease progression, a new analysis indicates. The findings suggest that melatonin may be beneficial ... Read more

January 14, 2021January 14, 2021

Pooling Imaging Data May Make Multi-center Clinical Trials Easier

News

Imaging data of brain inflammation in people with amyotrophic lateral sclerosis (ALS) that is obtained using different tracers and imaging equipment can be combined using a technique called the “pseudo ... Read more

January 6, 2021January 6, 2021

Human Cell Model Captures Brain and Muscle Interaction for 1st Time

News

A system using human cells to model how the brain controls muscle movement has been developed for the first time, and scientists expect it to aid in understanding neurological disorders ... Read more

December 21, 2020December 21, 2020

Target ALS Awards 4 Grants for Work Into Biomarker Discovery

News

Target ALS, a nonprofit working to advance research, has awarded a second round of grants supporting four projects that aim to discover and develop biomarkers for amyotrophic lateral sclerosis (ALS). ... Read more

December 15, 2020December 15, 2020

QurAlis Working on New ALS Therapy to Harness Benefits Without Side Effects

News

Researchers at QurAlis have discovered a molecule with the potential to act as a treatment for amyotrophic lateral sclerosis (ALS), in addition to a new therapeutic target for the disease. ... Read more

December 9, 2020December 9, 2020

Ezogabine Decreases Motor Neuron Excitability in ALS Clinical Trial

News

The anticonvulsant ezogabine can significantly reduce abnormal motor neuron excitability in people with amyotrophic lateral sclerosis (ALS), a clinical trial has found. The findings support further investigation of ezogabine, and ... Read more

Pin It on Pinterest